AUXL Financial Facts

Loss from operations: -5.09M
Selling, general and administrative: 44.31M
See Full Income Statement

Accumulated other comprehensive income: -248K
Deferred rent, current portion: 2.18M
See Full Balance Sheet

Earnings History for Auxilium Pharmaceuticals Inc. (AUXL)

  |   Expand Research on AUXL
Next EPS Date 7/30/13 *Est. EPS Growth Rate -25.0% *Last Qtr.
Average EPS % Beat Rate -100.5% Revenue Growth Rate -10.1% *Last Qtr.
Average % Move 1-Wk after EPS -1.9%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
4/29/13 Q113 -$0.05$0.02 -$0.07$66.2M$81.23M N/A / N/A = 0% Details
2/26/13 Q412 $1.83$1.72 +$0.11$172.5M$171.2M N/A / N/A = -11.8% Details
11/7/12 Q312 -$0.21-$0.04 -$0.17$71M$79.35M N/A / N/A -25.1% Details
7/31/12 Q212 $0.16-$0.06 +$0.22$78.2M$73.97M N/A / N/A -41.8% Details
5/10/12 Q112 -$0.04-$0.12 +$0.08$73.6M$71.21M N/A / N/A -14% Details
2/23/12 Q411 -$0.25-$0.16 -$0.09$73.3M$73.53M N/A / N/A -20% Details
10/31/11 Q311 -$0.08-$0.21 +$0.13$66.7M$66.83M N/A / N/A N/A 0% Details
8/1/11 Q211 -$0.11-$0.21 +$0.10$65.9M$65.03M N/A / N/A N/A -19.9% Details
Like AUXL Earnings? Also take a look at BSTC, GSK, PFE, WPI

AUXL Earnings News